• OPEN AN ACCOUNT
Indian Indices
Nifty
24,734.30 19.25
(0.08%)
Sensex
80,718.01 150.30
( 0.19%)
Bank Nifty
54,075.45 7.90
( 0.01%)
Nifty IT
35,143.10 -331.85
( -0.94%)
Global Indices
Nasdaq
45,277.53 -39.28
(-0.09%)
Dow Jones
6,467.55 31.01
(0.48%)
Hang Seng
42,536.01 597.12
(1.42%)
Nikkei 225
9,216.87 38.88
(0.42%)
Forex
USD-INR
88.06 -0.06
(-0.06%)
EUR-INR
102.67 -0.52
(-0.50%)
GBP-INR
118.27 -0.96
(-0.81%)
JPY-INR
0.59 0.00
(-0.78%)

EQUITY - MARKET SCREENER

Naman In-Store (India) Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
92621
INE0RJM01010
60.750116
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NAMAN
17.98
113.02
EPS(TTM)
Face Value()
Div & Yield %
4.81
10
0
 

Biogen Pharmachem Industries standalone net profit rises 59.46% in the March 2025 quarter
May 24,2025
Net profit of Biogen Pharmachem Industries rose 59.46% to Rs 1.18 crore in the quarter ended March 2025 as against Rs 0.74 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.29 crore in the year ended March 2025 as against net profit of Rs 1.93 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.